213 related articles for article (PubMed ID: 7783568)
41. Molecular analysis of the multidrug transporter.
Germann UA
Cytotechnology; 1993; 12(1-3):33-62. PubMed ID: 7765331
[TBL] [Abstract][Full Text] [Related]
42. Ailanthone reverses multidrug resistance by inhibiting the P-glycoprotein-mediated efflux in resistant K562/A02 cells.
Han F; Liu G; Sun C; Wei J
Cell Mol Biol (Noisy-le-grand); 2018 Dec; 64(15):55-61. PubMed ID: 30672437
[TBL] [Abstract][Full Text] [Related]
43. Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein.
Watanabe T; Uchiyama N; Roninson IB; Cohen D; Atadja P
Int J Oncol; 2000 Sep; 17(3):579-86. PubMed ID: 10938401
[TBL] [Abstract][Full Text] [Related]
44. Can nuclear medicine predict response to chemotherapy?
Moretti JL; Caglar M; Duran-Cordobes M; Morere JF
Eur J Nucl Med; 1995 Feb; 22(2):97-100. PubMed ID: 7758509
[No Abstract] [Full Text] [Related]
45. Multidrug resistance in leukemias and its reversal.
Malayeri R; Filipits M; Suchomel RW; Zöchbauer S; Lechner K; Pirker R
Leuk Lymphoma; 1996 Nov; 23(5-6):451-8. PubMed ID: 9031075
[TBL] [Abstract][Full Text] [Related]
46. Characterization of an ATP-binding cassette transporter in Cryptosporidium parvum.
Perkins ME; Volkman S; Wirth DF; Le Blancq SM
Mol Biochem Parasitol; 1997 Jul; 87(1):117-22. PubMed ID: 9233681
[No Abstract] [Full Text] [Related]
47. Drugs as P-glycoprotein substrates, inhibitors, and inducers.
Kim RB
Drug Metab Rev; 2002; 34(1-2):47-54. PubMed ID: 11996011
[No Abstract] [Full Text] [Related]
48. Multidrug resistance: overcoming the good, the bad, and the ugly.
Rund D
Leuk Lymphoma; 2010 Oct; 51(10):1771-2. PubMed ID: 20846098
[No Abstract] [Full Text] [Related]
49. Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression.
Chao CC
FEBS Lett; 1995 Oct; 373(3):285-90. PubMed ID: 7589484
[TBL] [Abstract][Full Text] [Related]
50. Nucleotide triphosphatase activity of the N-terminal nucleotide-binding domains of the multidrug resistance proteins P-glycoprotein and MRP1.
Wilkes DM; Wang C; Aristimuño PC; Castro AF; Altenberg GA
Biochem Biophys Res Commun; 2002 Aug; 296(2):388-94. PubMed ID: 12163030
[TBL] [Abstract][Full Text] [Related]
51. Purification and reconstitution of functional human P-glycoprotein.
Ambudkar SV
J Bioenerg Biomembr; 1995 Feb; 27(1):23-9. PubMed ID: 7629047
[TBL] [Abstract][Full Text] [Related]
52. Design of new drug molecules to be used in reversing multidrug resistance in cancer cells.
Mayur YC; Peters GJ; Prasad VV; Lemo C; Sathish NK
Curr Cancer Drug Targets; 2009 May; 9(3):298-306. PubMed ID: 19442050
[TBL] [Abstract][Full Text] [Related]
53. Multidrug resistance in the chronic lymphoproliferative disorders.
Drain S; Catherwood MA; Alexander HD
Leuk Lymphoma; 2010 Oct; 51(10):1793-804. PubMed ID: 20615085
[TBL] [Abstract][Full Text] [Related]
54. Lung resistance-related protein: determining its role in multidrug resistance.
Dalton WS; Scheper RJ
J Natl Cancer Inst; 1999 Oct; 91(19):1604-5. PubMed ID: 10511581
[No Abstract] [Full Text] [Related]
55. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy.
Wacher VJ; Wu CY; Benet LZ
Mol Carcinog; 1995 Jul; 13(3):129-34. PubMed ID: 7619215
[No Abstract] [Full Text] [Related]
56. Effects of phosphorylation of P-glycoprotein on multidrug resistance.
Germann UA; Chambers TC; Ambudkar SV; Pastan I; Gottesman MM
J Bioenerg Biomembr; 1995 Feb; 27(1):53-61. PubMed ID: 7629052
[TBL] [Abstract][Full Text] [Related]
57. P-glycoprotein in adult hematologic malignancies.
Marie JP
Hematol Oncol Clin North Am; 1995 Apr; 9(2):239-49. PubMed ID: 7642463
[TBL] [Abstract][Full Text] [Related]
58. Functional analysis of a tryptophan-less P-glycoprotein: a tool for tryptophan insertion and fluorescence spectroscopy.
Kwan T; Loughrey H; Brault M; Gruenheid S; Urbatsch IL; Senior AE; Gros P
Mol Pharmacol; 2000 Jul; 58(1):37-47. PubMed ID: 10860925
[TBL] [Abstract][Full Text] [Related]
59. A bioassay for the activity of PSC 833 in human serum for modulation of P-glycoprotein-mediated multidrug resistance.
Uchiyama-Kokubu N; Watanabe T; Nakajima M
Anticancer Drugs; 2000 Aug; 11(7):583-90. PubMed ID: 11036963
[TBL] [Abstract][Full Text] [Related]
60. Role of gene amplification in drug resistance.
Schoenlein PV
Cancer Treat Res; 1994; 73():167-200. PubMed ID: 7710905
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
